Invesco’s AbbVie ABBV Stock Holding History

Invesco’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.7B	Sell	7,798,048 -309,432	-4%	-$68.6M	0.17%	106
2025 Q4	$1.85B	Buy	8,107,480 +668,658	+9%	+$152M	0.17%	96
2025 Q3	$1.72B	Buy	7,438,822 +442,207	+6%	+$90.1M	0.27%	48
2025 Q2	$1.3B	Sell	6,996,615 -1,370,434	-16%	-$255M	0.22%	73
2025 Q1	$1.75B	Buy	8,367,049 +1,246,863	+18%	+$242M	0.33%	36
2024 Q4	$1.27B	Sell	7,120,186 -638,196	-8%	-$117M	0.23%	63
2024 Q3	$1.53B	Buy	7,758,382 +2,079,684	+37%	+$388M	0.3%	44
2024 Q2	$974M	Buy	5,678,698 +360,492	+7%	+$59.7M	0.21%	87
2024 Q1	$968M	Buy	5,318,206 +49,891	+0.9%	+$8.6M	0.21%	85
2023 Q4	$816M	Sell	5,268,315 -1,063,733	-17%	-$155M	0.19%	95
2023 Q3	$944M	Sell	6,332,048 -292,483	-4%	-$42.9M	0.25%	58
2023 Q2	$893M	Sell	6,624,531 -1,470,727	-18%	-$216M	0.23%	76
2023 Q1	$1.29B	Sell	8,095,258 -902,953	-10%	-$138M	0.36%	35
2022 Q4	$1.45B	Buy	8,998,211 +523,667	+6%	+$80.3M	0.43%	23
2022 Q3	$1.14B	Buy	8,474,544 +659,564	+8%	+$94.6M	0.37%	37
2022 Q2	$1.2B	Buy	7,814,980 +1,648,278	+27%	+$252M	0.36%	44
2022 Q1	$1,000M	Buy	6,166,702 +294,978	+5%	+$42.8M	0.26%	64
2021 Q4	$795M	Buy	5,871,724 +739,492	+14%	+$87.4M	0.19%	106
2021 Q3	$554M	Buy	5,132,232 +294,395	+6%	+$33.6M	0.14%	168
2021 Q2	$545M	Sell	4,837,837 -130,514	-3%	-$14.7M	0.13%	175
2021 Q1	$538M	Buy	4,968,351 +817,182	+20%	+$87.4M	0.14%	167
2020 Q4	$445M	Buy	4,151,169 +165,439	+4%	+$15.9M	0.13%	180
2020 Q3	$349M	Buy	3,985,730 +532,295	+15%	+$50.1M	0.12%	196
2020 Q2	$339M	Buy	3,453,435 +1,200,007	+53%	+$106M	0.12%	192
2020 Q1	$172M	Sell	2,253,428 -1,609,739	-42%	-$137M	0.07%	334
2019 Q4	$342M	Sell	3,863,167 -387,517	-9%	-$32.2M	0.11%	238
2019 Q3	$322M	Sell	4,250,684 -113,658	-3%	-$7.79M	0.08%	279
2019 Q2	$317M	Buy	4,364,342 +1,429,584	+49%	+$112M	0.08%	294
2019 Q1	$237M	Buy	2,934,758 +340,108	+13%	+$27.8M	0.08%	290
2018 Q4	$239M	Sell	2,594,650 -780,377	-23%	-$68.6M	0.09%	252
2018 Q3	$319M	Buy	3,375,027 +14,888	+0.4%	+$1.41M	0.1%	217
2018 Q2	$311M	Buy	3,360,139 +983,076	+41%	+$96M	0.1%	216
2018 Q1	$225M	Sell	2,377,063 -544,553	-19%	-$59.8M	0.08%	264
2017 Q4	$283M	Sell	2,921,616 -2,840,560	-49%	-$268M	0.1%	227
2017 Q3	$512M	Buy	5,762,176 +82,034	+1%	+$6.24M	0.19%	127
2017 Q2	$412M	Buy	5,680,142 +1,049,532	+23%	+$70.6M	0.13%	173
2017 Q1	$302M	Sell	4,630,610 -2,076,221	-31%	-$131M	0.1%	229
2016 Q4	$420M	Sell	6,706,831 -767,876	-10%	-$46.9M	0.14%	160
2016 Q3	$471M	Buy	7,474,707 +477,125	+7%	+$30.9M	0.16%	133
2016 Q2	$433M	Sell	6,997,582 -1,017,373	-13%	-$62M	0.16%	142
2016 Q1	$458M	Buy	8,014,955 +334,908	+4%	+$18.7M	0.19%	118
2015 Q4	$455M	Sell	7,680,047 -200,587	-3%	-$11.6M	0.18%	114
2015 Q3	$429M	Sell	7,880,634 -405,011	-5%	-$26.4M	0.18%	115
2015 Q2	$557M	Buy	8,285,645 +683,119	+9%	+$44.6M	0.22%	97
2015 Q1	$445M	Sell	7,602,526 -477,440	-6%	-$28.8M	0.17%	131
2014 Q4	$529M	Buy	8,079,966 +75,690	+0.9%	+$4.77M	0.2%	111
2014 Q3	$462M	Buy	8,004,276 +3,646,679	+84%	+$202M	0.18%	121
2014 Q2	$246M	Buy	4,357,597 +1,408,077	+48%	+$73.9M	0.1%	259
2014 Q1	$152M	Sell	2,949,520 -552,690	-16%	-$27.9M	0.06%	367
2013 Q4	$185M	Buy	3,502,210 +178,284	+5%	+$8.76M	0.07%	319
2013 Q3	$149M	Sell	3,323,926 -201,567	-6%	-$8.94M	0.06%	351
2013 Q2	$146M	Buy	+3,525,493	New	+$154M	0.07%	338

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco's ABBV Position: Q1 2026 in Review

Invesco reduced its AbbVie (ABBV) stake by 3.8% in Q1 2026, selling an estimated $68.6M and leaving 7,798,048 shares worth $1.7B. The position accounts for 0.17% of the portfolio, ranked #106.

Invesco first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.85B in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Invesco held 7,798,048 shares of AbbVie worth $1.7B as of Q1 2026.
Invesco sold 309,432 AbbVie shares in Q1 2026, an estimated $68.6M.
AbbVie made up 0.17% of Invesco's portfolio in Q1 2026, its #106 holding.
Invesco first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Invesco's AbbVie position peaked at $1.85B in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.